Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
29.09.25
/
50%
€37.40
Target price
29.09.26
€65.69
Performance (%)
1.60%
Price
24.02.26
€38.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 1.60%. This prediction currently runs until 29.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 2.703% | 2.703% |
| iShares Core DAX® | 0,02 % | 0,58 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % |
| iShares S&P 500 | 1,33 % | 0,14 % |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $65.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€39.40
06.01.26
06.01.26
€68.23
06.01.27
06.01.27
-3.55%
24.02.26
24.02.26
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€64.64
23.05.25
23.05.25
-42.86%
24.05.25
24.05.25